Changing the manufacturer of antiepileptic drugs - what are the risks?
Webcast with Ms. Wittig-Moßner, Dr. Lang and Prof. Hamer
What impact can a change of dosage form or manufacturer of an anticonvulsant have on patients? And what possible risks need to be considered in this case?
In this video, Ms. Wittig-Moßner, Chairwoman of the self-help groups in Bavaria, Dr. Lang and Prof. Hamer from the Epilepsy Center Erlangen jointly discuss current study data on this topic. They also discuss the challenges that arise in the day-to-day care of patients with epilepsy.
